Abstract
Background The ATHENA COVID-19 (ACV19) study was set up to recruit a cohort of patients with linked health information willing to be re-contacted in future to participate in clinical trials, and also to investigate the outcomes of people with COVID-19 in Queensland, Australia, using consent. This report describes how patients were recruited, their primary care data extracted, proportions consenting, outcomes of using the recontact method to recruit to a study, and experiences interacting with general practices requested to release the primary care data.
Methods Patients diagnosed with COVID-19 from January 1st, 2020, to December 31st, 2020, were systematically approached to gain consent to have their primary healthcare data extracted from their general practice into a Queensland Health database and linked to other datasets for ethically approved research. Patients were also asked to consent to allow future recontact to discuss participation in clinical trials and other research studies. Patients who consented to recontact were later approached to recruit to a long-COVID study. Patients’ general practices were contacted to export the patient files. All patient and general practice interactions were recorded. Outcome measures were proportions of patients consenting to data extraction and research, permission to recontact, proportions of general practices agreeing to participate. A thematic analysis was conducted to assess attitudes regarding export of healthcare data, and the proportions consenting to participate in the long-COVID study also reported.
Results Out of 1212 patients with COVID-19, contact details were available for 1155; 995(86%) were successfully approached, and 842(85%) reached a consent decision. Of those who reached a decision, 581(69%), 615(73%) and 629(75%) patients consented to data extraction, recontact, and both, respectively. 382 general practices were contacted, of whom 347(91%) had an electronic medical record compatible for file export. Of these, 335(88%) practices agreed to participate, and 12(3%) declined. In total 526 patient files were exported. The majority of general practices supported the study and accepted electronic patient consent as legitimate. For the long COVID study, 376(90%) of those patients recontacted agreed to have their contact details passed onto the long COVID study team and 192(53%) consented to take part in their study.
Conclusions This report describes how primary care data was successfully extracted using consent, and that the majority of patients approached gave permission for their healthcare information to be used for research and be recontacted. The consent-to-recontact concept demonstrated its effectiveness to recruit to new research studies. The majority of general practices were willing to export identifiable patient healthcare data for linkage provided consent had been obtained.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding was provided by the Health Innovation Investment and Research Office, Queensland Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Gold Coast Human Research Ethics Committee, gave ethical approval for this work (HREC/2020/QGC/63555) on 24th April 2020
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
List of Abbreviations
- ACV19
- ATHENA COVID-19
- ATHENA
- Australians Together Health Initiative
- COVID-19
- Coronavirus disease 2019
- GP
- General practice
